Device Trial Radar · NCT07851038
Focused Ultrasound for Behavioral Health
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Oct 19, 2026
Primary completion
Apr 5, 2028
Study completion May 17, 2028
Sponsor
- Lead sponsor
- Attune Neurosciences IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of California, San Francisco; University of Pennsylvania
- First posted
- Oct 1, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, within-participant crossover, multi-site dose-finding study evaluating the safety, feasibility, and preliminary efficacy of repeated low-intensity focused ultrasound (LIFU) stimulation using the ATTN201 device across seven candidate deep-brain targets in adults with subsyndromal-to-moderate depression, anxiety, or obsessive-compulsive disorder. Every session delivers active ATTN201 stimulation; there is no sham or placebo condition. Participants and the on-site study staff who deliver stimulation and administer the clinical scales are blinded to the brain target and to the stimulation parameters assigned for each session by a constrained Bayesian optimization algorithm.
Conditions
- Depression
- Anxiety
- Obsessive Compulsive Disorder (OCD)
Interventions
ATTN201 head-worn focused ultrasoundDevice
ATTN201 head-worn focused ultrasound
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient-specific transdiagnostic score (TDx) at 1 week after stimulationTime frame: 1 week after each stimulation session
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Attune Neurosciences, Inc.
San Francisco, California · Not yet recruiting
Attune, San Francisco Clinical Research Center
San Francisco, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.